301226-83-5 Usage
Chemical compound
Piperidine derivative
It is a derivative of the piperidine ring, which is a common structural motif in many pharmaceutical compounds and organic molecules.
BOC protecting group
tert-butoxycarbonyl
The BOC group is attached to the nitrogen atom in the molecule, providing protection during chemical reactions and preventing unwanted side reactions.
Pyridin-2-ylamino group
Attached to the piperidine ring
This functional group is responsible for the unique reactivity and properties of the compound, making it a potential building block for the synthesis of various pharmaceutical compounds and organic molecules.
Reagent
Used in chemical reactions
1-BOC-4-(PYRIDIN-2-YLAMINO)PIPERIDINE is commonly used as a reagent in chemical reactions, facilitating the formation of new bonds and the synthesis of more complex molecules.
Starting material
Organic synthesis
It serves as a starting material in organic synthesis, allowing chemists to build upon its structure to create a wide range of compounds with diverse applications.
Pharmaceutical applications
Development and production of new drugs
Due to its unique structure and reactivity, 1-BOC-4-(PYRIDIN-2-YLAMINO)PIPERIDINE is important for the development and production of new drugs and other pharmaceutical products.
Potential uses
Building block for various organic molecules
Its unique structure and functional groups make it a valuable building block for the synthesis of a wide range of organic molecules with potential applications in various fields, including pharmaceuticals, materials science, and chemical research.
Check Digit Verification of cas no
The CAS Registry Mumber 301226-83-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,1,2,2 and 6 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 301226-83:
(8*3)+(7*0)+(6*1)+(5*2)+(4*2)+(3*6)+(2*8)+(1*3)=85
85 % 10 = 5
So 301226-83-5 is a valid CAS Registry Number.
301226-83-5Relevant articles and documents
HETEROCYCLIC COMPOUND, APPLICATION THEREOF, AND COMPOSITION CONTAINING SAME
-
, (2022/03/07)
A heterocyclic compound represented by formula XI, a pharmaceutically acceptable salt, a solvate, or a solvate of a pharmaceutically acceptable salt thereof, use thereof, and a composition containing the same. The compound is novel in structure and has good STAT5 inhibitory activity.
HYDROXYQUINOXALINECARBOXAMIDE DERIVATIVE
-
Page/Page column 53, (2010/12/29)
The present invention provides a novel hydroxyquinoxaline carboxamide derivative that is useful for preventing and/or treating blood coagulation disorders. A compound represented by formula (i), or a pharmacologically acceptable salt thereof: wherein, each of R1 and R2 independently represents a group such as a hydrogen atom or a halogen atom; R3 represents a group such as a hydrogen atom; each of R4 and R5 independently represents a group such as a hydrogen atom, a halogen atom or a C1-4 alkyl group; each of R6 and R7 independently represents a hydrogen atom or a C1-4 alkyl group; X represents a group such as a C3-10 cycloalkyl group, C6-10 aryl group or a 5- to 10-membered heterocyclic group, which may be substituted with substituent(s) selected from substituent group α; Y represents a group such as -CO-, -O- or -NRa-, and Ra represents a group such as a hydrogen atom or a C1-4 alkyl group.
BENZIMIDAZOLE ANTAGONISTS OF THE H-3 RECEPTOR
-
Page/Page column 21, (2010/11/27)
This invention is directed to a compound of formula (I), as defined herein, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition containing a compound of formula (I), a process of preparation of a compound of formula (I), a method o
